0 followers
Rafael Holdings (NYSE: RFL) is focused on the development of novel cancer therapies. The Company is a significant investor in two clinical stage oncology companies-- Rafael Pharmaceuticals, Inc. and LipoMedix Pharmaceuticals Ltd.
SenesTech
2 followers
Kyverna Therapeutics
6 followers
Day One Biopharmaceuticals
1 follower
Ventyx Biosciences
1 follower
Abcuro
1 follower
Odyssey Therapeutics
2 followers
Thermo Fisher Scientific
172 followers
Genentech
158 followers
Gilead Sciences
132 followers
Biogen
118 followers
Regeneron
100 followers
Explore companies